Newsroom

Welcome to Blood Cancer United Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Research June 30, 2022

Faron Pharmaceuticals Announces the Private Placement of EUR 5 Million, Including LLS TAP

TURKU, FINLAND / BOSTON, MA, June 28, 2022 - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company foc…

News June 30, 2022

The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member

News June 28, 2022

The Leukemia & Lymphoma Society Launches First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia

The global leader in the fight against blood cancers, The Leukemia & Lymphoma Society (LLS), announced the launch of its Pediatric Acute Leukemia (Ped…

News June 27, 2022

LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling

LLS Remains Committed to Advocating for Cancer Patients in Wake of Dobbs Ruling

News June 24, 2022

Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of Lymphoma

Patient Education Webcasts June 22, 2022

Addressing the Financial Impact of Cancer

News June 22, 2022

America’s Youngest Generation is Trailblazing the Way for a Future without Cancer

The Leukemia & Lymphoma Society Announces Winners of 2022 National Students of the Year Philanthropic Competition …

Patient Education Webcasts June 17, 2022

Caregiving Over Coffee: An Interactive Q&A with Dr. Mitchell

Research June 13, 2022

ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline

Marseille, France, June 13, 2022 – ImCheck Therapeutics announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird…

News June 6, 2022